|
Lot Number L16815 |
Device Problem
Temperature Problem (3022)
|
Patient Problems
Purulent Discharge (1812); Burn, Thermal (2530)
|
Event Type
Injury
|
Event Description
|
Burn with discharge of pus [thermal burn].Burn with discharge of pus [purulent discharge].Case description: this is a spontaneous report from a contactable pharmacist received via pfizer consumer healthcare (pch).A male patient of an unspecified age and ethnicity started to use thermacare heatwrap (thermacare heatwrap, lot# l16815), from an unspecified date to an unspecified date at an unspecified frequency for an unspecified indication.The patient medical history and concomitant medications were not reported.On an unspecified date, the patient suffered from burn with discharge of pus requiring unspecified medical care/treatment.The outcome of the events was unknown.The action taken in response to the events for thermacare heatwrap was unknown.Additional information has been requested and will be provided as it becomes available.Company clinical evaluation comment: based on the information provided, the events burn with discharge of pus as described in this case are considered serious bodily injury potentially requiring medical intervention to prevent permanent damage or impairment of body structure, assessed as associated with the use of the device.This case meets initial 10-day (b)(6) and 30-day fda reportability.Case comment: based on the information provided, the events burn with discharge of pus as described in this case are considered serious bodily injury potentially requiring medical intervention to prevent permanent damage or impairment of body structure, assessed as associated with the use of the device.This case meets initial 10-day (b)(6) and 30-day fda reportability.
|
|
Manufacturer Narrative
|
The plant has reviewed this batch from a manufacturing and technical perspective.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.After a review of the batch thermal records, thermal results all met product release criteria.Consumer alleges burn from wrap.The cause of the alleged burn is inconclusive since review of records does not provide evidence to support defective product.The product effect may vary with each individual.
|
|
Event Description
|
Case description: this is a spontaneous report from a contactable (b)(6) received via pfizer consumer healthcare (pch).A male patient of an unspecified age and ethnicity started to use thermacare heatwrap (thermacare heatwrap) (lot #: l16815) from an unspecified date at an unspecified frequency for an unspecified indication.The patient's medical history and concomitant medications were not reported.On an unspecified date, the patient suffered from burn with discharge of pus requiring unspecified medical care/treatment.Action taken in response to the events for thermacare heatwrap was unknown.Clinical outcome of the events was unknown.New information received from product quality complaint (pqc) group includes investigation results.The plant has reviewed this batch from a manufacturing and technical perspective.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.After a review of the batch thermal records, thermal results all met product release criteria.Consumer alleges burn from wrap.The cause of the alleged burn is inconclusive since review of records does not provide evidence to support defective product.The product effect may vary with each individual.Additional information has been requested and will be provided as it becomes available.Follow up ((b)(6) 2016): new information received from product quality complaints (pqc) group included: product quality investigation results.Follow-up attempts completed.No further information expected.Company clinical evaluation comment: based on the information provided, the events burn with discharge of pus as described in this case are considered serious bodily injury potentially requiring medical intervention to prevent permanent damage or impairment of body structure, assessed as associated with the use of the device.This case meets final 10-day eu and 30-day fda reportability.Case comment: based on the information provided, the events burn with discharge of pus as described in this case are considered serious bodily injury potentially requiring medical intervention to prevent permanent damage or impairment of body structure, assessed as associated with the use of the device.This case meets final 10-day eu and 30-day fda reportability.Evaluation summary: the plant has reviewed this batch from a manufacturing and technical perspective.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.After a review of the batch thermal records, thermal results all met product release criteria.Consumer alleges burn from wrap.The cause of the alleged burn is inconclusive since review of records does not provide evidence to support defective product.The product effect may vary with each individual.
|
|
Search Alerts/Recalls
|
|
|